Clinical trial
Efficacy of Fluoxetine in Reducing Ictal Hypoventilation in Patients With Partial Epilepsy
NCT00986310 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Fluoxetine in Reducing Ictal Hypoventilation in Patients With Partial Epilepsy
- Lead sponsor
- University of California, Davis
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 31, 2009
- Completion date
- June 30, 2012
- Enrollment
- 2 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ictal hypoventilation, uncontrolled partial epilepsy